by GlobeNewsWire | Feb 19, 2016 | Globe Newswire
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Feb. 19, 2016 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation (Nasdaq:AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of...
by GlobeNewsWire | Jan 20, 2016 | Globe Newswire, GNW Alerts
GAINESVILLE, Fla. and CAMBRIDGE, Mass. and PHILADELPHIA, Jan. 20, 2016 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation (Nasdaq:AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for...
by GlobeNewsWire | Dec 15, 2015 | Globe Newswire
GAINESVILLE, Fla., and CAMBRIDGE, Mass., Dec. 15, 2015 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation (Nasdaq:AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of...
by GlobeNewsWire | Sep 30, 2015 | Globe Newswire
GAINESVILLE, Fla., Sept. 30, 2015 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation (Nasdaq:AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare eye diseases,...
by GlobeNewsWire | Sep 10, 2015 | Globe Newswire
GAINESVILLE, Fla., Sept. 10, 2015 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation (NASDAQ:AGTC), a clinical stage biotechnology company developing adeno-associated virus (AAV)-based gene therapies for the treatment of rare eye diseases, today...
